TrialClinical drug investigation2017
Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings.
Constance H Keyserling et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it